FDA — authorised 17 February 2006
- Application: NDA021632
- Marketing authorisation holder: VICURON HOLDINGS
- Indication: Type 1 - New Molecular Entity
- Status: approved
🇺🇸 Eraxis in United States
FDA authorised Eraxis on 17 February 2006
Marketing authorisation
Eraxis in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Eraxis approved in United States?
Yes. FDA authorised it on 17 February 2006.
Who is the marketing authorisation holder for Eraxis in United States?
VICURON HOLDINGS holds the US marketing authorisation.